Post‐neoadjuvant assessment of tumour budding according to <scp>ITBCC</scp> subgroups delivers stage‐ and <scp>regression‐grade</scp> independent prognostic information in intestinal‐type gastric adenocarcinoma-Reference-Cited by-同舟云学术

Post‐neoadjuvant assessment of tumour budding according to ITBCC subgroups delivers stage‐ and regression‐grade independent prognostic information in intestinal‐type gastric adenocarcinoma

Published:2022-06-17 Issue:5 Volume:8 Page:448-457
ISSN:2056-4538
Container-title:The Journal of Pathology: Clinical Research
language:en
Short-container-title:The Journal of Pathology CR

Author:

Jesinghaus Moritz¹²^ORCID,Herz Anna‐Lina²,Kohlruss Meike²,Silva Miguel²,Grass Albert¹,Lange Sebastian³⁴,Novotny Alexander⁵,Ott Katja⁶,Schmidt Thomas⁷⁸,Gaida Matthias⁹,Hapfelmeier Alexander¹⁰¹¹,Denkert Carsten¹,Weichert Wilko²⁴¹²,Keller Gisela²^ORCID

Affiliation:

1. Institute of Pathology University Hospital Marburg Marburg Germany

2. Institute of Pathology Technical University Munich Munich Germany

3. II Medizinische Klinik, Klinikum rechts der Isar Technical University Munich Munich Germany

4. German Cancer Consortium (DKTK), Partner Site Munich Munich Germany

5. Department of Surgery, Klinikum rechts der Isar Technical University Munich Munich Germany

6. Department of Surgery Klinikum Rosenheim Rosenheim Germany

7. Department of Surgery University of Heidelberg Heidelberg Germany

8. Department of Surgery University Hospital Köln Köln Germany

9. Institute of Pathology University Hospital Heidelberg Heidelberg Germany

10. Institute of General Practice and Health Services Research Technical University Munich Munich Germany

11. Institute for AI and Informatics in Medicine, School of Medicine Technical University Munich Munich Germany

12. Comprehensive Cancer Center Munich (CCCM) Munich Germany

Publisher

Wiley

Subject

Pathology and Forensic Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cjp2.284

Reference46 articles.

1. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries

2. National Comprehensive Cancer Network.Gastric Cancer. National Comprehensive Cancer Network (NCCN) Guidelines. Version 1.2020.2020. Available from:https://www.nccn.org/professionals/physician_gls/pdf/gastric.pdf

3. Current treatment and recent progress in gastric cancer

4. Gastric cancer: a comprehensive review of current and future treatment strategies

5. Perioperative Chemotherapy versus Surgery Alone for Resectable Gastroesophageal Cancer

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tumor Budding Should Be in Oral Cavity Cancer Reporting: A Retrospective Cohort Study Based on Tumor Microenvironment;Cancers;2023-08-01

2. Tumor budding in gastric cancer;World Journal of Gastrointestinal Surgery;2023-04-27

3. Tumor budding as a predictor for prognosis and therapeutic response in gastric cancer: A mini review;Frontiers in Oncology;2023-01-23

4. Clinicopathological characteristics of signet‐ring cell carcinoma derived from gastric fovelar epithelium;Journal of Digestive Diseases;2022-07